Tag: COVID-19
Filter by:
Building a New Frontier in Pandemic Risk Modelin...
Since 2020 and the start of the COVID-19 pandemic, we have all been acutely aware of the wide-ranging impact that pandemics can have in terms…
2023 Nobel Prize in Physiology or Medicine Award...
A benchmark for modeling progress in the field of human longevity is the Nobel Prize in Physiology or Medicine, which has been awarded…
Moody’s RMS 2022 Catastrophe Review: Another Exa...
'It only takes one.' This mantra was already top of mind for the insurance industry after 2021 and Hurricane Ida, and once again it turned out…
Living To 100: Society of Actuaries Symposium 2023
The triennial Society of Actuaries ‘Living to 100 Symposium’ was held in Orlando, Florida, (January 16-18, 2023), a unique conference that…
Quantifying Inflation for the (Re)insurance Indu...
Since the publication of the RMS whitepaper Inflationary Trends in Construction Costs and Nat Cat Losses in Recent Events in May 2022 (…
FDA Grants Accelerated Approval For Alzheimer’s ...
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…